Wellcome Trust


Mucosis brings in $4M for development of first RSV vaccine

Dutch biotech company, Mucosis, announced on Wednesday that it secured a $4 million fund awarded from the Wellcome Trust foundation. This will go toward clinical trials – a phase I dose-finding and safety study, followed by a novel phase II challenge study to assess the efficacy for its respiratory syncytial virus (RSV) intranasal vaccine called SynGEM. […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.


PTC Therapeutics gets $5 million drug development award

PTC Therapeutics has received a $5 million Seeding Drug Discovery award from UK charity Wellcome Trust to support the development of small-molecule drugs to battle life-threatening infections caused by multi-drug-resistant, Gram-negative bacteria. The South Plainfield, New Jersey-based drug development company’s anti-infective program is “currently in lead optimization and advancing toward identifying a development candidate,” according […]